News

In an effort to help facilitate accurate and uniform records of US vaccine usage, the Centers for Disease Control and Prevention (CDC) and immunization community stakeholders are exploring the potential of 2-dimensional (2D) barcoding to streamline immunization practices.

At least one quarter of the 800,000 deaths annually attributed to cardiovascular disease could be prevented if people stopped smoking, reduced salt intake, and adopted other healthy habits, according to a report by the U.S. Centers for Disease Control and Prevention (CDC).

Knowing which patients are most at-risk for adverse drug events would help hospitals direct pharmacist-led counseling services to those who need it the most. The American Society of Health-System Pharmacists (ASHP) Foundation is funding research it believes will make it easier to identify those patients.

In state that opt out of Medicaid expansion, millions of low-income people will miss out on subsidies too

New regulations in the Patient Protection and Affordable Care Act have led to the birth of essential health benefits. The Centers for Medicare and Medicaid Services’ (CMS) new division, the Center for Consumer Information and Insurance Oversight (CCIIO), is responsible for the oversight of the insurance offerings on the new health insurance exchanges, which have 10 required essential health benefit categories. One of these essential categories is prescription drugs. Prospective qualified health plans, prescription benefit managers, and consultant agencies have struggled through the legislation and guidance from CCIIO in an attempt to build benefits that meet the requirements. With elements of typical commercial offerings as well as those of Medicare Part D, there are many nuances that one must consider when building an exchange formulary and creating the surrounding benefit.

Guillain-Barre syndrome (GBS) is an immune-mediated flaccid paralysis that can range from muscle weakness and tingling to respiratory paralysis requiring prolonged respiratory support and ventilation. Overall, GBS is a rare disease, with annual incidence averaging 1 to 2 cases per 100,000 individuals.1

Catamaran, a pharmacy benefits manager (PBM) has been on a buying binge since 2008, snapping up its sixth PBM, Restat. The $409.5 million cash purchase is expected to close in the fourth quarter of 2013.

In a study of patients with alcohol dependence and post-traumatic stress disorder (PTSD), treatment with naltrexone resulted in a decrease in the percentage of patient drinking days. Prolonged exposure therapy was not associated with an exacerbation of alcohol-use disorder.

Kaiser Permanente (KP) Northern California nearly doubled the rate of blood pressure control among adult members with diagnosed hypertension between 2001 and 2009 through a large-scale community-based program, the Journal of the American Medical Association reported recently.

Despite grim predictions of rate shock, older and sicker people will experience 'rate joy' in the exchanges

Prevalence of chronic pain can add up to higher costs in mental-health and medical claims

With the start date fast approaching, health insurers are searching for potential strategies to avoid or minimize the fee

Catamaran is buying lives and contracts in its race to grow larger, fill in niche gaps, and increase revenue

HIPAA rules expect health organizations to protect and secure a wide variety of personal data

Nurses also identify lifestyle issues during yearly kitchen table conversations

Costly chronic conditions increase with age

HHS will use aggregated data to analyze health plans’ risk pools and administer reinsurance by tapping into Edge Servers

In Iowa, the Blue Zones Project has community buy-in

Workers have their own ideas on who's getting the best deal in health coverage

Delaware's law aims to increase access while plans manage 15% annual trend in specialty drugs

Plans want more and better data on drug quality

A survey of New Jersey physicians reveals concern about reimbursement and changes to practice structures

In a Drug Safety Communication, FDA has reported that a patient in Europe being treated for multiple sclerosis and who had no history of using natalizumab (Tysabri) developed progressive multifocal leukoencephalopathy (PML) while taking fingolimod (Gilenya).

Eleven states have reduced antipsychotic use in nursing home residents by at least 15%, meeting a CMS partnership goal set last year.

The new fixed-combination of brinzolamide 1% plus brimonidine 0.2% (Simbrinza Suspension, Alcon Laboratories) is a safe and effective option for lowering IOP in patients with glaucoma or ocular hypertension uncontrolled on monotherapy.

One in 10 Americans admit taking someone else’s Rx, according to an ongoing Reuters/psos online survey. About a quarter of those people used the prescription drugs to get high, according to the survey